Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Abstract Background Few studies have examined the impact of treatment-related morbidity on long-term, cause-specific mortality in Hodgkin lymphoma (HL) patients. Methods This multicenter cohort included 4919 HL patients, treated before age 51 years between 1965 and 2000, with a median follow-up of 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2021-06, Vol.113 (6), p.760-769
Hauptverfasser:	de Vries, Simone, Schaapveld, Michael, Janus, Cécile P M, Daniëls, Laurien A, Petersen, Eefke J, van der Maazen, Richard W M, Zijlstra, Josée M, Beijert, Max, Nijziel, Marten R, Verschueren, Karijn M S, Kremer, Leontien C M, van Eggermond, Anna M, Lugtenburg, Pieternella J, Krol, Augustinus D G, Roesink, Judith M, Plattel, Wouter J, van Spronsen, Dick Johan, van Imhoff, Gustaaf W, de Boer, Jan Paul, Aleman, Berthe M P, van Leeuwen, Flora E
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular diseases Cause of Death Chemotherapy Cohort Studies Confidence intervals Health hazards Hodgkin Disease - drug therapy Hodgkin's lymphoma Humans Infectious diseases Irradiation Life expectancy Life span Lymphoma Middle Aged Morbidity Mortality Neoplasm Recurrence, Local Neoplasms, Second Primary - epidemiology Patients Population (statistical) Radiation therapy Risk Factors Solid tumors Spleen Splenectomy Survival Survivors Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!